About Dolnośląskie Centrum Onkologii; Oddział Onkologii Klinicznej i Chemioterapii
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Dolnośląskie Centrum Onkologii; Oddział Onkologii Klinicznej i Chemioterapii
During the past decade, Dolnośląskie Centrum Onkologii; Oddział Onkologii Klinicznej i Chemioterapii conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Dolnośląskie Centrum Onkologii; Oddział Onkologii Klinicznej i Chemioterapii
According to Clinical.Site data, the most researched conditions in "Dolnośląskie Centrum Onkologii; Oddział Onkologii Klinicznej i Chemioterapii" are
"Biliary Tract Cancer" (1 trials), "Breast Cancer" (1 trials), "Carcinoma, Hepatocellular" (1 trials), "Esophageal Squamous Cell Carcinoma" (1 trials) and "Non-small Cell Lung Cancer (NSCLC)" (1 trials). Many other conditions were trialed in "Dolnośląskie Centrum Onkologii; Oddział Onkologii Klinicznej i Chemioterapii" in a lesser frequency.
Clinical Trials Intervention Types at Dolnośląskie Centrum Onkologii; Oddział Onkologii Klinicznej i Chemioterapii
Most popular intervention types in "Dolnośląskie Centrum Onkologii; Oddział Onkologii Klinicznej i Chemioterapii" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (4 trials), "Placebo" (3 trials), "Bevacizumab" (2 trials), "Tiragolumab" (2 trials) and "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Dolnośląskie Centrum Onkologii; Oddział Onkologii Klinicznej i Chemioterapii
The vast majority of trials in "Dolnośląskie Centrum Onkologii; Oddział Onkologii Klinicznej i Chemioterapii" are
6 trials for "All" genders.
Clinical Trials Status at Dolnośląskie Centrum Onkologii; Oddział Onkologii Klinicznej i Chemioterapii
Currently, there are NaN active trials in "Dolnośląskie Centrum Onkologii; Oddział Onkologii Klinicznej i Chemioterapii".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Dolnośląskie Centrum Onkologii; Oddział Onkologii Klinicznej i Chemioterapii,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Dolnośląskie Centrum Onkologii; Oddział Onkologii Klinicznej i Chemioterapii, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".